Cimoxatone
Clinical data | |
---|---|
ATC code | none |
Identifiers | |
| |
CAS Number | 73815-11-9 |
PubChem (CID) | 52542 |
ChemSpider | 47493 |
UNII | V6FT1QJ7VL |
KEGG | D02581 |
ChEMBL | CHEMBL2104092 |
ECHA InfoCard | 100.070.537 |
Chemical and physical data | |
Formula | C19H18N2O4 |
Molar mass | 338.36 g/mol |
| |
(what is this?) (verify) |
Cimoxatone (MD 780515) is a reversible inhibitor of MAO-A (RIMA).[1] It has a significant food interaction–related adverse effect in combination with tyramine.[2] It was never marketed.
See also
References
- ↑ Nair NP, Ahmed SK, Kin NM, West TE (1995). "Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients". Acta Psychiatr Scand Suppl. 386: 28–35. doi:10.1111/j.1600-0447.1995.tb05921.x. PMID 7717092.
- ↑ Nair NP, Ahmed SK, Kin NM (November 1993). "Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide". J Psychiatry Neurosci. 18 (5): 214–25. PMC 1188542. PMID 7905288.
This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.